Clinical Trials Browser

Phase 1/2 × Adjuvants, Immunologic × Dermatologic × Clear all

NCT00365937 2019-03-06

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Phase 1/2 Terminated

Melanoma